Cat.#: ACPP-1251
| Despition | EAAT2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
| ACPP-1566 | Human STMN1 Protein (AC1566) | 5 µg | inquiry |
| ACPP-1430 | Human Pleiotrophin Protein, His (AC1430) | 5 µg | inquiry |
| ACPP-1741 | Human NDRG1 Protein (AC1741) | 10 µg | inquiry |
| ACPP-1047 | Recombinant Human Myelin Basic Protein Protein (Fc Tag) (AC1047) | 50 µg | inquiry |
| ACPP-1039 | Recombinant Human FGFR4 Protein (6×His Tag) (AC1039) | 50 µg | inquiry |
| ACPP-1354 | PAX2 Blocking Peptide (AC1354) | 250 µg | inquiry |
| ACPP-1007 | Recombinant Human Secretogranin 3 Protein (6×His Tag) (AC1007) | 50 µg | inquiry |
| ACPP-1084 | Recombinant Human Autotaxin Protein (Functional) (AC1084) | 10 µg | inquiry |
| ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.